*NORIFUMI IIJIMA1, Koki Sakurai2,1, Masaya Yamaguchi3, Kozue Yamada-Uchio1, Miwa Sasai9, Yoshinobu Oyama1,2, Chitoku Toda5, Takatoshi Hikida2, Masahiro Oka1, Yoshihiro Yoneda4, Bojan Polic6, Marc Schmidt-Supprian7, David A Leib8 (1. National Institutes of Biomedical Innovation, Health and Nutrition, 2. Osaka University Institute for Protein Research, 3. Osaka University Graduate School of Dentistry, 4. The Research Foundation for Microbial Diseases of Osaka University, 5. Fuculty of Life Sciences, Kumamoto University, 6. Faculty of Medicine, University of Rijeka, 7. TUM School of Medicine and Health, 8. Dartmouth’s Geisel School of Medicine, 9. Research Institute for Microbial Diseases, Osaka University)
Session information
Oral
[1O01e] Neurological diseases 1
Wed. Jul 24, 2024 5:00 PM - 6:00 PM Room 1 (Main Hall)
Chairperson: Koji Yamanaka (Nagoya University, Reserach Institute of Environmental Medicine), Atsushi Sugie (Brain Research Institute, Niigata University)
*Cyril Jones Jagaraj1, Angela Laird1, Julie Atkin1,2 (1. MND Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, 2. La Trobe Institute for Molecular Science, La Trobe University)
*Yohei iguchi1, Yuhei Takahashi1, Jiayi Li1, Yoshinobu Amakusa1, Yu Kawakami1, Satoshi Yokoi1, Masahisa katsuno1 (1. Nagoya University)
*Kazuhide Asakawa1,2, Hiroshi Handa3, Koichi Kawakami1,2 (1. National Institute of Genetics, 2. SOKENDAI, 3. Tokyo Medical University)